Search Results - "Ruder, Josefine"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Dynamics of Inflammatory and Neurodegenerative Biomarkers after Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis by Ruder, Josefine, Dinner, Gianna, Maceski, Aleksandra, Berenjeno-Correa, Ernesto, Müller, Antonia Maria, Jelcic, Ilijas, Kuhle, Jens, Martin, Roland

    “…Autologous hematopoietic stem cell transplantation (aHSCT) is a highly efficient treatment of multiple sclerosis (MS), and hence it likely normalizes…”
    Get full text
    Journal Article
  2. 2

    NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis by Ruder, Josefine, Rex, Jordan, Obahor, Simon, Docampo, María José, Müller, Antonia M S, Schanz, Urs, Jelcic, Ilijas, Martin, Roland

    Published in Frontiers in immunology (16-12-2021)
    “…Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, in which autoreactive T and B cells play important roles. Other lymphocytes…”
    Get full text
    Journal Article
  3. 3

    Enhanced and cross-reactive in vitro memory B cell response against Epstein-Barr virus nuclear antigen 1 in multiple sclerosis by Marti, Zoe, Ruder, Josefine, Thomas, Olivia G, Bronge, Mattias, De La Parra Soto, Lorenzo, Grönlund, Hans, Olsson, Tomas, Martin, Roland

    Published in Frontiers in immunology (2024)
    “…Multiple sclerosis (MS) is a prototypical autoimmune disease of the central nervous system (CNS). In addition to CD4 T cells, memory B cells are now recognized…”
    Get full text
    Journal Article
  4. 4

    Dynamics of T cell repertoire renewal following autologous hematopoietic stem cell transplantation in multiple sclerosis by Ruder, Josefine, Docampo, María José, Rex, Jordan, Obahor, Simon, Naghavian, Reza, Müller, Antonia M S, Schanz, Urs, Jelcic, Ilijas, Martin, Roland

    Published in Science translational medicine (02-11-2022)
    “…Autologous hematopoietic stem cell transplantation (aHSCT) is a highly effective treatment of multiple sclerosis (MS). It depletes autoreactive cells and…”
    Get more information
    Journal Article
  5. 5

    Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson’s Disease Substantia Nigra by Grünblatt, Edna, Ruder, Josefine, Monoranu, Camelia Maria, Riederer, Peter, Youdim, Moussa BH, Mandel, Silvia A.

    Published in Neurotoxicity research (01-04-2018)
    “…Parkinson’s disease is the most common neurodegenerative disorder after Alzheimer’s disease, with the majority of cases being sporadic or “idiopathic”. The…”
    Get full text
    Journal Article
  6. 6

    B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis by von Niederhäusern, Valentin, Ruder, Josefine, Ghraichy, Marie, Jelcic, Ilijas, Müller, Antonia Maria, Schanz, Urs, Martin, Roland, Trück, Johannes

    “…BACKGROUND AND OBJECTIVESAutologous hematopoietic stem cell transplantation (aHSCT) is increasingly used to treat aggressive forms of multiple sclerosis (MS)…”
    Get full text
    Journal Article
  7. 7

    Alterations of Thymus-Derived Tregs in Multiple Sclerosis by Lorenzini, Tiziana, Faigle, Wolfgang, Ruder, Josefine, Docampo, María José, Opitz, Lennart, Martin, Roland

    “…Multiple sclerosis (MS) is considered a prototypic autoimmune disease of the CNS. It is the leading cause of chronic neurologic disability in young adults…”
    Get full text
    Journal Article